A new perspective on macrophage-targeted drug research: the potential of KDELR2 in bladder cancer immunotherapy
IntroductionBladder cancer was recognized as one of the most common malignant tumors in the urinary system, and treatment options remained largely limited to conventional surgery, radiotherapy, and chemotherapy, which limited patient benefits.MethodsResearchers constructed an RNA transcriptome map o...
Saved in:
| Main Authors: | Zhiyi Zhao, Hongling Jia, Zhou Sun, Yumeng Li, Lingyun Liu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-12-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1485109/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
KDELR3 overexpression as a novel prognostic and diagnostic biomarker in glioma: comprehensive bioinformatic analysis insights
by: Jing Feng, et al.
Published: (2024-12-01) -
Tumor-associated macrophages in bladder cancer: roles and targeted therapeutic strategies
by: Yuanchun Ma, et al.
Published: (2024-11-01) -
Tumor-associated macrophages promote bladder cancer metastasis through the CCL20-CCR6 axis
by: Ryunosuke Nakagawa, et al.
Published: (2025-02-01) -
Intraperitoneal Administration of S100A8 Ameliorates Experimental Acute Colitis in Rats
by: Kano Matsuo, et al.
Published: (2024-11-01) -
Immunotherapies to Nano-Immunotherapies: Advances in Immune Targeting in Bladder Cancer
by: Beatriz Ramos, et al.
Published: (2025-02-01)